Globeflex Capital’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Globeflex Capital’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-28	Closed	-$2K	–	547
2019 Q2	$2K	Buy	+28	New	+$1.45K	﹤0.01%	493
2016 Q4	–	Sell	-57,194	Closed	-$1M	–	559
2016 Q3	$1M	Buy	57,194 +44	+0.1%	+$730	0.25%	148
2016 Q2	$977K	Buy	+57,150	New	+$1.02M	0.27%	142

Other funds holding ARNA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Globeflex Capital's ARNA Position: Q3 2019 in Review

Globeflex Capital sold out of Arena Pharmaceuticals Inc (ARNA) in Q3 2019, closing a stake of 28 shares — an estimated $2K sold.

Globeflex Capital first reported a position in ARNA in Q2 2016 and held it in 3 quarters. The position peaked at $1M in Q3 2016. 230 funds tracked by Wall St. Rank hold ARNA as of Q3 2019.

Globeflex Capital reported no remaining Arena Pharmaceuticals Inc position as of Q3 2019 after selling out during the quarter.
Globeflex Capital sold 28 Arena Pharmaceuticals Inc shares in Q3 2019, an estimated $2K.
Globeflex Capital first reported a position in Arena Pharmaceuticals Inc in Q2 2016 and held it in 3 quarters.
Globeflex Capital's Arena Pharmaceuticals Inc position peaked at $1M in Q3 2016.
230 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q3 2019.

Based on Globeflex Capital's 13F filing for Q3 2019, filed 13 Nov 2019.